Form 8-K - Current report:
SEC Accession No. 0001493152-25-009548
Filing Date
2025-03-07
Accepted
2025-03-07 16:05:13
Documents
14
Period of Report
2025-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43382
2 ex10-1.htm EX-10.1 49806
  Complete submission text file 0001493152-25-009548.txt   278581

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pxmd-20250228.xsd EX-101.SCH 3018
4 XBRL LABEL FILE pxmd-20250228_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE pxmd-20250228_pre.xml EX-101.PRE 24167
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3683
Mailing Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591
Business Address 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591 914-987-2876
PaxMedica, Inc. (Filer) CIK: 0001811623 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41475 | Film No.: 25719986
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)